- Generic name
- Tranexamic Acid
- Strength
- 250 mg/5 ml
- Dosage form
- Injection
- Manufactured by
- Renata PLC.
Xamic Injection
About Xamic 250 mg/5 ml Injection
Xamic is a tranexamic acid injection made by Renata PLC. It comes as a 250 mg/5 ml strength and is given by a healthcare professional, usually in a hospital or clinic setting, to help control bleeding.
There are 35 brands of Tranexamic Acid listed in Bangladesh. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.
What is Xamic 250 mg/5 ml Injection?
Xamic injection is a product of Renata PLC. It contains tranexamic acid, a medicine classed as an anti-fibrinolytic drug. It works against the breakdown of blood clots, which is why it is used in situations where bleeding needs to be controlled. It is given by injection, so a doctor or nurse administers it. The strength shown on the pack is 250 mg/5 ml. The doctor decides the dose and course for each person. Ask the doctor or pharmacist if you have questions about this medicine.
Uses of Xamic
Xamic is used to prevent and treat bleeding in several medical and surgical situations. These include bleeding from the lungs and the digestive tract, bleeding linked to leukaemia, cirrhosis and haemophilia, and some bleeding problems during clot-dissolving treatment or transfusion. It is also used around operations, including lung and heart surgery. Only the doctor can confirm whether it suits a particular person.
How to use Xamic
Xamic is given by injection, so it is handled by a doctor or nurse; you do not give it to yourself. The doctor decides the dose and how long it is given, based on the reason for treatment and the person's condition. Tell the healthcare team about all medicines you take, including oral contraceptives and clot-dissolving drugs, before it is given. Ask the doctor or pharmacist about anything you do not understand.
Side effects of Xamic
Many people tolerate tranexamic acid well, but some side effects can occur. These include tiredness, eye irritation, a blocked nose, itching, skin redness and rash. Nausea, diarrhoea and stomach burning have been reported after oral use. A drop in blood pressure on standing is rare. If there are signs of an allergic reaction, treatment is stopped and the doctor manages it. Report any unusual feeling to the healthcare team.
Safety and precautions
Xamic should not be used by anyone allergic to tranexamic acid or with a history of thromboembolic disease, arterial or venous thrombosis, bleeding inside body cavities, or serious kidney failure. It is not to be given during known or suspected pregnancy. It passes into breast milk in small amounts, so discuss breastfeeding with the doctor. People with kidney problems need medical review first. Tell the doctor about all other medicines. The doctor or pharmacist should be asked about any concern before use.
Frequently asked questions
What do the injection form and the 250 mg/5 ml strength mean?
Xamic is supplied as a liquid for injection, so it is given by a healthcare professional rather than swallowed. The strength 250 mg/5 ml describes how much tranexamic acid is present in each 5 ml of the liquid. The doctor decides the dose and course.
What is Xamic used for and what kind of medicine is it?
Xamic is an anti-fibrinolytic medicine containing tranexamic acid. It is used to prevent and treat bleeding in various medical and surgical conditions, such as bleeding from the lungs or digestive tract, bleeding related to some blood and liver disorders, and bleeding during certain operations.
What does the generic name tranexamic acid mean?
The generic name is the common name of the active ingredient, tranexamic acid, which is the same substance used in other brands of this medicine. Xamic is the brand name given by Renata PLC. Knowing the generic name helps you and your doctor identify the medicine.
Who should be told before Xamic is given?
Tell the doctor or pharmacist if you are pregnant or breastfeeding, have kidney problems, have had a blood clot, or take other medicines such as oral contraceptives or clot-dissolving drugs. They will decide whether it is suitable and how it should be managed.
Also available as
Indications
In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.
In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.
In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.
In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.
In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.
In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.
Pharmacology
The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.
Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.
Dosage & Administration
- The usual dose: 500-1000 mg 3 times daily.
- For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
- For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
- For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
- For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Interaction
Contraindications
Side Effects
- Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
- After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
- There are rare cases of postural hypotension.
- In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.
Pregnancy & Lactation
Precautions & Warnings
- Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
- The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
- In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
- Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
- The administration of product requires particular care in cardiopathic and hepatopathic subjects.
Storage Conditions
Alternative brands of Tranexamic Acid
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.